Trovafloxacin neurotoxicity.
Menzies
D
D
Klein
N C
NC
Cunha
B A
BA
D000368:Aged; D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003221:Confusion / Q000139:chemically induced; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced; D005260:Female; D024841:Fluoroquinolones / Q000009:adverse effects* / Q000627:therapeutic use; D005684:Gait / Q000187:drug effects; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000139:chemically induced; D008875:Middle Aged; D009287:Naphthyridines / Q000009:adverse effects* / Q000627:therapeutic use; D009422:Nervous System Diseases / Q000139:chemically induced*; D014202:Tremor / Q000139:chemically induced
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D009287:Naphthyridines; C080163:trovafloxacin